Two FDA advisory panels have voted unanimously to recommend that a birth control pill, called Opill, become available without a prescription, which would make it the first birth control pill available for over-the-counter sales in the United States. The FDA is not required to follow the recommendation, but the vote is expected to weigh heavily on its final decision, expected in late summer. Advocates argue that over-the-counter access to birth control would make it more accessible and reduce the need for doctor visits.